5-羟基-四氢萘酮抑制鼠伤寒沙门菌入侵及体内保护效果研究OA
Inhibitory Effects of 5-Hydroxy-1-tetralone on Salmonella typhimurium Invasion and Its Protective Efficacy In Vivo
为探究5-羟基-四氢萘酮对沙门菌毒力岛-1(SPI-1)及其III型分泌系统(T3SS-1)功能的抑制作用和机制,本试验通过药代动力学和毒性预测、生长曲线测定、细胞入侵试验、免疫荧光成像、效应蛋白分泌和表达检测、细菌运动能力评估、入侵位点细胞膜褶皱观察、实时荧光定量聚合酶链式反应(qPCR)、细胞毒性和细胞保护试验,并结合小鼠感染模型,系统评价5-羟基-四氢萘酮对鼠伤寒沙门菌的体内外抗毒力活性及其分子机制.结果显示,预测5-羟基-四氢萘酮具有良好的成药性;与对照组(0 µg/mL)相比,64 µg/mL 5-羟基-四氢萘酮对鼠伤寒沙门菌生长速度无显著影响(P>0.05);16和4 µg/mL 5-羟基-四氢萘酮分别显著抑制鼠伤寒沙门菌对人宫颈癌细胞系HeLa(P<0.01)和人结肠癌细胞系Caco-2(P<0.05)的入侵;8 µg/mL 5-羟基-四氢萘酮显著抑制鼠伤寒沙门菌效应蛋白SipA和SipB的分泌(P<0.05);16和32 µg/mL 5-羟基-四氢萘酮分别显著抑制SipA和HilA蛋白相对表达量(P<0.05);64和32 µg/mL 5-羟基-四氢萘酮分别显著抑制鼠伤寒沙门菌的泳动(P<0.05)和群集运动能力(P<0.01),32 µg/mL 5-羟基-四氢萘酮极其显著降低鼠伤寒沙门菌诱导宿主细胞膜褶皱的能力(P<0.001),并极显著下调SPI-1相关转录因子及下游基因的转录(P<0.01或P<0.001);64 µg/mL 5-羟基-四氢萘酮对HeLa细胞无明显毒性(P>0.05),32 µg/mL 5-羟基-四氢萘酮极其显著提高受感染细胞保护率(P<0.001);与模型组相比,5-羟基-四氢萘酮治疗组小鼠盲肠、肝脏和脾脏细菌载量均显著降低(P<0.05或P<0.01),炎性病理损伤明显改善.结果表明,5-羟基-四氢萘酮可作为一种高效的鼠伤寒沙门菌T3SS-1抑制剂,为针对鼠伤寒沙门菌抗毒力药物的开发提供了机制较为明确的先导化合物.
To investigate the inhibitory effects and underlying mechanisms of 5-hydroxy-1-tetralone on Salmonella pathogenicity island-1(SPI-1)and its type III secretion system(T3SS-1),this study systematically evaluated the anti-virulence activity of 5-hydroxy-1-tetralone both in vitro and in vivo.The experimental approaches included pharmacokinetic and toxicity prediction,growth curve analysis,cell invasion assays,immunofluorescence imaging,detection of effector protein secretion and expression,assessment of bacterial motility,observation of host cell membrane ruffling at invasion sites,real-time fluorescence quantitative polymerase chain reaction(qPCR),cytotoxicity and cell protection assays,together with a mouse infection model.The results indicated that 5-hydroxy-1-tetralone exhibited favorable drug-likeness properties.Compared with the Control group(0 µg/mL),64 µg/mL 5-hydroxy-1-tetralone had no significant effect on the growth rate of S.typhimurium(P>0.05).Treatment with 16 and 4 µg/mL 5-hydroxy-1-tetralone significantly inhibited bacterial invasion into human cervical carcinoma HeLa cells(P<0.01)and human colon carcinoma Caco-2 cells(P<0.05),respectively.At 8 µg/mL,5-hydroxy-1-tetralone significantly suppressed the secretion of the effector proteins SipA and SipB in S.typhimurium(P<0.05).Moreover,16 and 32 µg/mL 5-hydroxy-1-tetralone significantly reduced the relative expression levels of SipA and HilA proteins,respectively(P<0.05).Treatment with 64 and 32 µg/mL 5-hydroxy-1-tetralone significantly inhibited swimming(P<0.05)and swarming motility of S.typhimurium(P<0.01).In addition,32 µg/mL 5-hydroxy-1-tetralone markedly reduced the ability of S.typhimurium to induce host cell membrane ruffling(P<0.001)and significantly downregulated the transcription of SPI-1-associated transcriptional regulators and downstream genes(P<0.01 or P<0.001).Furthermore,64 µg/mL 5-hydroxy-1-tetralone showed no obvious cytotoxicity to HeLa cells(P>0.05),while 32 µg/mL 5-hydroxy-1-tetralone significantly increased the protection rate of infected cells(P<0.001).In the mouse infection model,bacterial loads in the cecum,liver,and spleen were significantly reduced in the 5-hydroxy-1-tetralone treatment group compared with the Model group(P<0.05 or P<0.01),accompanied by marked improvement in inflammatory pathological damage.These findings demonstrate that 5-hydroxy-1-tetralone acts as an efficient inhibitor of the S.typhimurium T3SS-1 and represents a promising lead compound with a relatively well-defined mechanism for the development of anti-virulence therapeutics targeting S.typhimurium.
李雪瑜;柳加洋;葛津利;刘洪涛;邱家章
吉林大学动物医学学院,吉林 长春 130062吉林大学动物医学学院,吉林 长春 130062吉林大学动物医学学院,吉林 长春 130062吉林大学动物医学学院,吉林 长春 130062吉林大学动物医学学院,吉林 长春 130062
农业科技
5-羟基-四氢萘酮鼠伤寒沙门菌沙门菌毒力岛-1(SPI-1)抗毒力
5-hydroxy-1-tetraloneSalmonella typhimuriumSalmonella pathogenicity island-1(SPI-1)anti-virulence
《中国兽医杂志》 2026 (4)
1-11,11
国家重点研发计划(2021YFD1801000)
评论